OTC · Financial Statements
Elixinol Wellness Limited (ELLXF) Financial Statements
$0.01
OTC: ELLXF
Market Cap $1.63M
Overview Financials Dividend
Elixinol Wellness Limited most recently reported annual revenue of $15.0M, a net loss of $5.0M. Revenue was roughly flat over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $9.0M $7.0M $8.0M $15.0M $15.0M Operating Profit $-16.0M $-10.0M $-6.0M $-5.0M $-5.0M Net Profit $-17.0M $-11.0M $-8.0M $-2.0M $-5.0M EPS $-0.04 $-0.03 $-0.10 $-0.01 $-0.02 Op Margin -167.2% -141.8% -78.2% -34.1% -32.1%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $25.0M $13.0M $12.0M $18.0M $16.0M Total Liabilities $6.0M $4.0M $5.0M $8.0M $9.0M Cash $13.0M $3.0M $1.0M $1.0M $1.0M Borrowings $3.0M $2.0M $1.0M $2.0M $4.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $-14.0M $-8.0M $-3.0M $-3.0M $-3.0M Investing Cash Flow $0 $-1.0M $-1.0M $2.0M $0 Financing Cash Flow $-1.0M $-1.0M $-1.0M $-2.0M $0 Net Cash Flow $-15.0M $-10.0M $-2.0M $0 $0 Free Cash Flow $-14.0M $-8.0M $-3.0M $-4.0M $-3.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.79 FCF Yield -251.38% Quick Ratio 0.46 Interest Coverage -9.10 Return 1Y -73.21% Return 3Y -89.41% Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .